• About
    • Our Mission
    • Threat of AMR
    • Access and Appropriate Use Principles
    • Our Investors
  • Team
  • Investments
    • How We Invest
    • Our Portfolio
    • Get On Our Radar
  • News
  • Connect

Posts about In the News:

  • All
  • In the News
  • Press Releases
  • Media
April 10, 2025
In the News

Op-ed: The Growing Threat That Superbugs Pose to Cancer Patients

Read More +
April 3, 2025
In the News

European Biotech: Innovation in AMR needs a viable market

Read More +
March 19, 2025
In the News

Biotech-Finances: Q&A with AMR Action Fund CEO Henry Skinner

Read More +
January 7, 2025
In the News

Southern California Public Radio: How prepared are we for XDR bacteria?

Read More +
December 18, 2024
In the News

LA Times: Doctors identify 'alarming' new strain of drug-resistant bacteria in Los Angeles

Read More +
November 25, 2024
In the News

The Hill Times Op-Ed: Canada Must Not Delay Action on AMR

Read More +
November 13, 2024
In the News

Harvard Public Health Op-Ed: Superbugs and Hurricanes

Read More +
October 16, 2024
In the News

AMR Action Fund Expands Portfolio with Investment in TenNor Therapeutics

Read More +
Previous page Next page
contact-bg-img

Connect With Us

Contact
footer_logo

Enabling
Breakthroughs in
Antimicrobials

Stay connected

Stay up-to-date on our work to bring 2 to 4 new antibiotics to patients by the end of the decade. When we have news, we will let you know.

  • About
  • Team
  • Latest
  • Threat of AMR
  • Connect
  • Investments
  • Japan Disclaimer
  • Privacy Policy